Fundraising FoxTerra Venture Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Infiniplexinfiniplex.lifeinMay 2022
Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments.
BiotechDeep TechDigital Health
Alon Shalev(CEO)inZeev Russak(CTO)inEfrat Herscovitch(CFO)Asa Eitan(CSO)
Co-investorsBosch Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.